Readiness for HIV Postexposure Prophylaxis (PEP) Decision Making Following Sexual Violence

被引:0
|
作者
Moret, Jessica Draughon [1 ]
Wilson, Machelle [2 ]
Humphrey-Staub, Jacke [1 ]
Porter, Tequila [1 ]
Wellington, Jessica [3 ]
Anderson, Jocelyn C. [4 ]
机构
[1] Univ Calif Davis, Betty Irene Moore Sch Nursing, Davis, CA 95616 USA
[2] Univ Calif Davis, Clin & Translat Sci Ctr, Dept Publ Hlth Sci, Div Biostat, Davis, CA USA
[3] Penn State Univ, Nese Coll Nursing, University Pk, PA USA
[4] Univ Arkansas Med Sci, Coll Nursing, Little Rock, AR USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDIMENSIONAL SCALE; ANTIRETROVIRAL THERAPY; MALE VICTIMS; ASSAULT; ADHERENCE; PREVENTION; EXPOSURE; RAPE; PREVALENCE;
D O I
10.1080/01612840.2024.2366324
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
HIV post-exposure prophylaxis (PEP) can reduce the risk of acquiring HIV infection following sexual assault. However, only about half of people offered HIV PEP will initiate the medication. Factors associated with patient readiness for HIV PEP following sexual assault have been attributed to structural and clinical barriers. This study utilized the Theory of Reasoned Action and Planned Behavior to better understand how personal factors, cognitive factors, mental health, barriers and facilitators that could influence a patient's decision to start HIV PEP post sexual assault. A web-based cross sectional survey was conducted from October 2017 to January 2020 and a total of 228 responses were included from participants that had experienced sexual assault in the previous 3 months. Using linear regression modeling fear of HIV, post-traumatic stress symptoms, validating social responses to disclosure, and having someone else pay for HIV PEP were all associated with feeling better prepared for HIV PEP decision making. Results indicate that structural, social, and individual factors impact patient decision making. These findings highlight opportunities for health systems and providers to improve HIV education and the importance of initiating HIV PEP following sexual assault.
引用
收藏
页码:937 / 947
页数:11
相关论文
共 50 条
  • [31] THE PRIORITY OF ADMINISTERING HIV POSTEXPOSURE PROPHYLAXIS IN CASES OF SEXUAL ASSAULT IN AN EMERGENCY DEPARTMENT
    Scannell, Meredith
    MacDonald, Andrea E.
    Berger, Amanda
    Boyer, Nichole
    JOURNAL OF EMERGENCY NURSING, 2018, 44 (02) : 117 - +
  • [32] HIV Postexposure Prophylaxis After Sexual Assault: Why Is It So Hard to Accomplish?
    Cohen, Myron S.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (12) : 979 - 980
  • [33] Nonoccupational Postexposure Human Immunodeficiency Virus Prophylaxis Acceptance Following Sexual Assault
    Moret, Jessica E. Draughon
    Hauda, William E., II
    Price, Bonnie
    Sheridan, Daniel J.
    NURSING RESEARCH, 2016, 65 (01) : 47 - 54
  • [34] Current Practice of HIV Postexposure Prophylaxis Treatment for Sexual Assault Patients in an Emergency Department
    Krause, Kathleen H.
    Lewis-O'Connor, Annie
    Berger, Amanda
    Votto, Teress
    Yawetz, Sigal
    Pallin, Daniel J.
    Baden, Lindsey R.
    WOMENS HEALTH ISSUES, 2014, 24 (04) : E407 - E412
  • [35] HIV nonoccupational postexposure prophylaxis for sexual assault cases: a 3-year investigation
    Shipeolu, Lolade
    Sampsel, Kari
    Reeves, Allegra
    Blaskovits, Farriss
    Heimerl, Melissa
    Muldoon, Katherine
    AIDS, 2020, 34 (06) : 869 - 876
  • [36] Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM)
    Palich, Romain
    Martin-Blondel, Guillaume
    Cuzin, Lise
    Le Talec, Jean-Yves
    Boyer, Pierre
    Massip, Patrice
    Delobel, Pierre
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 (07) : 493 - 498
  • [37] Potentially preventable occupational percutaneous injuries (PIs) resulting in human immunodeficiency virus (HIV) postexposure prophylaxis (PEP).
    Campbell, S
    Srivastava, P
    Cardo, D
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (09): : 686 - 686
  • [38] Can emergency departments fulfil BASHH recommendations for 24-hour access to HIV postexposure prophylaxis following sexual exposure?
    Arkell, P.
    Abouyannis, M.
    Manavi, K.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (01) : 75 - 76
  • [39] Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States
    Pinkerton, SD
    Martin, JN
    Roland, ME
    Katz, MH
    Coates, T
    Kahn, JO
    AIDS, 2004, 18 (15) : 2065 - 2073
  • [40] Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior
    Martin, JN
    Roland, ME
    Neilands, TB
    Krone, MR
    Bamberger, JD
    Kohn, RP
    Chesney, MA
    Franses, K
    Kahn, JO
    Chesney, MA
    Franses, K
    Kahn, JO
    Coates, TJ
    Katz, MH
    AIDS, 2004, 18 (05) : 787 - 792